Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer
Clinical trial NCT04697628 · COMPLETED
Trial details
- NCT number
- NCT04697628
- Sponsor
- Seagen, a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-22
- Primary completion
- 2023-07-24
- Enrollment
- 502
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.